Date: 14 February, 2023
Time: 15:00 CET
The WHO R&D Blueprint organized an urgent meeting with the MARVAC partners to discuss vaccine and therapeutic candidates.
This urgent meeting was convened to outline proposed research priorities towards the newly identified Marburg outbreak in Equatorial Guinea.
Agenda
1- Outbreak sit rep including diagnostics and epi info
2- Review of core trial protocol (Ira Longini)
3- Review of available vaccines and status
4- Review on therapeutics
PRESENTATIONS:
Opening Remarks:Research and innovation as part of the response to outbreaks.
Current landscape of candidate vaccines against Marburg.
MARVAC discussions on a core protocol for clinical evaluation of candidate vaccines.
Current landscape of candidate therapeutics for Marburg.
Main conclusions and next steps.